From Tuskegee to a COVID Vaccine: Diversity and Racism Are Hurdles in Drug Trials
Tips
AMID A SEEMINGLY endless pandemic, as a spiraling number of COVID-19 deaths presage what could be a long, dark winter, the news broke through like thin rays of sunshine: Two American pharmaceutical giants racing to find a vaccine separately reported that human tests of their experimental drugs have shown highly promising results.
The potentially game-changing data from drug manufacturers Pfizer and Moderna, however, obscured what some say is another key development: Both companies reported that the pools of volunteers receiving the drugs included significant numbers of Black participants.
The views and opinions expressed in the article are solely those of their authors, and do not necessarily reflect the opinions and beliefs of UDiversity.com.
Comments (5)
Best Company Reply
Because Other Candidates
Aldus PageMaker including versions Reply
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce vel augue eget quam fermentum sodales. Aliquam vel congue sapien, quis mollis quam.